These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33824764)

  • 1. Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension.
    Aabed WJ; Radwan AH; Zaid AN; Shraim NY
    Int J Hypertens; 2021; 2021():6695744. PubMed ID: 33824764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and stability evaluation of extemporaneous oral suspension of valsartan using commercially available tablets.
    Zaid AN; Assali M; Qaddomi A; Ghanem M; Zaaror YA
    Int J Pharm Compd; 2014; 18(2):169-74. PubMed ID: 24881122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder.
    Zaid AN; Assali M; Zalmout S; Basheer A
    Eur J Hosp Pharm; 2017 May; 24(3):157-161. PubMed ID: 31156928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-friendly extemporaneous formulation of bisoprolol: application to stability and bioavailability studies.
    El-Masry SM; Helmy SA; Helmy SAM; Mazyed EA
    Drug Deliv Transl Res; 2023 Mar; 13(3):795-810. PubMed ID: 36192532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of extemporaneously prepared rosuvastatin oral suspension.
    Zaid AN; Shtayah R; Qadumi A; Ghanem M; Qedan R; Daibes M; Awwad SA; Jaradat N; Kittana N
    Am J Health Syst Pharm; 2017 Oct; 74(19):1579-1583. PubMed ID: 28947528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension.
    Foley L; Toney J; Barlow JW; O'Connor M; Fitzgerald-Hughes D; Ramtoola Z
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients.
    García MC; Manzo RH; Jimenez-Kairuz AF
    Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and stability of diazepam suspension compounded from tablets.
    Strom JG; Kalu AU
    Am J Hosp Pharm; 1986 Jun; 43(6):1489-91. PubMed ID: 3728485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stability of quetiapine oral suspension compounded from commercially available tablets.
    Tran J; Gervase MA; Evans J; Deville R; Dong X
    PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of commercially available suspending vehicles for extemporaneous compounding of cardiovascular medicines: physical and chemical stability mini review.
    Thrimawithana TR; D'Amore S; Dib Y; Fadavi Firooz N; Fakhouri W; Saeed A; Allahham A
    Pharm Dev Technol; 2019 Jun; 24(5):529-538. PubMed ID: 30238838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan.
    Musko M; Sznitowska M
    Acta Pharm; 2014 Dec; 64(4):463-74. PubMed ID: 25531786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of valsartan oral dosage forms.
    Sunkara G; Bende G; Mendonza AE; Solar-Yohay S; Biswal S; Neelakantham S; Wagner R; Flarakos J; Zhang Y; Jarugula V
    Clin Pharmacol Drug Dev; 2014 Mar; 3(2):132-8. PubMed ID: 27128457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of propranolol hydrochloride suspension compounded from tablets.
    Henry DW; Repta AJ; Smith FM; White SJ
    Am J Hosp Pharm; 1986 Jun; 43(6):1492-5. PubMed ID: 3728486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
    Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z
    Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and Chemical Stability of Mycophenolate Mofetil (MMF) Suspension Prepared at the Hospital.
    Fahimi F; Baniasadi S; Mortazavi SA; Dehghan H; Zarghi A
    Iran J Pharm Res; 2012; 11(1):171-5. PubMed ID: 24250439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
    Zhao F; Dave VS; Mar MZ; Perri JR
    Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of acetazolamide in suspension compounded from tablets.
    Alexander KS; Haribhakti RP; Parker GA
    Am J Hosp Pharm; 1991 Jun; 48(6):1241-4. PubMed ID: 1858804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes.
    Reindel K; Zhao F; Hughes S; Dave VS
    Hosp Pharm; 2017 Dec; 52(11):752-760. PubMed ID: 29276255
    [No Abstract]   [Full Text] [Related]  

  • 20. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
    Vojta J; Jedlička A; Coufal P; Janečková L
    J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.